These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Transplantation--a medical miracle of the 20th century. Morris PJ N Engl J Med; 2004 Dec; 351(26):2678-80. PubMed ID: 15616201 [No Abstract] [Full Text] [Related]
65. Immunology insights into cardiac allograft rejection. Savasta M; Lentini S Rev Cardiovasc Med; 2011; 12(2):e68-76. PubMed ID: 21796085 [TBL] [Abstract][Full Text] [Related]
66. Regulatory T cells as a therapeutic tool to induce solid-organ transplant tolerance: current clinical experiences. Nikoueinejad H; Sharif MR; Amirzargar A; Mirshafiey A; Einollahi B Exp Clin Transplant; 2013 Oct; 11(5):379-87. PubMed ID: 23902519 [TBL] [Abstract][Full Text] [Related]
67. An Update on Calcineurin Inhibitor-Free Regimens: The Need Persists, but the Landscape has Changed. Webber AB; Vincenti F Transplantation; 2016 Apr; 100(4):836-43. PubMed ID: 27003097 [TBL] [Abstract][Full Text] [Related]
68. The spectrum of complications of immunosuppression: is the time right for hand transplantation? Brenner MJ; Tung TH; Jensen JN; Mackinnon SE J Bone Joint Surg Am; 2002 Oct; 84(10):1861-70. PubMed ID: 12377920 [No Abstract] [Full Text] [Related]
69. Some observations on prope tolerance. Calne R; Watson CJ Curr Opin Organ Transplant; 2011 Aug; 16(4):353-8. PubMed ID: 21666472 [TBL] [Abstract][Full Text] [Related]
73. The Emerging Role of Nanotechnology in Cell and Organ Transplantation. Tasciotti E; Cabrera FJ; Evangelopoulos M; Martinez JO; Thekkedath UR; Kloc M; Ghobrial RM; Li XC; Grattoni A; Ferrari M Transplantation; 2016 Aug; 100(8):1629-38. PubMed ID: 27257995 [TBL] [Abstract][Full Text] [Related]
74. Immunosuppression in organ transplantation. Jordan SC; Rosenthal P; Makowka L Semin Pediatr Surg; 1993 Nov; 2(4):206-7. PubMed ID: 8062042 [TBL] [Abstract][Full Text] [Related]
75. Advances in immune-based therapies to improve solid organ graft survival. Rose SM; Turka L; Kerr L; Rotrosen D Adv Intern Med; 2001; 47():293-331. PubMed ID: 11795079 [No Abstract] [Full Text] [Related]
76. New goals to be achieved in clinical transplantation. Manez R Drug News Perspect; 2006 Oct; 19(8):509-12. PubMed ID: 17160153 [TBL] [Abstract][Full Text] [Related]
77. [Modern immunosuppression after solid organ transplantation]. Beimler J; Morath C; Zeier M Internist (Berl); 2014 Feb; 55(2):212-22. PubMed ID: 24518922 [TBL] [Abstract][Full Text] [Related]
78. Xenotransplantation. Bigam D; Zhong R; Levy G; Grant D Can J Surg; 1999 Feb; 42(1):12-6. PubMed ID: 10071582 [TBL] [Abstract][Full Text] [Related]
79. Chronic allograft dysfunction: mechanisms and new approaches to therapy. Womer KL; Vella JP; Sayegh MH Semin Nephrol; 2000 Mar; 20(2):126-47. PubMed ID: 10746856 [TBL] [Abstract][Full Text] [Related]
80. Micro and nanoparticle drug delivery systems for preventing allotransplant rejection. Fisher JD; Acharya AP; Little SR Clin Immunol; 2015 Sep; 160(1):24-35. PubMed ID: 25937032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]